The Christie is playing a leading role in shaping national cancer care, with the appointment of Dr Robert Metcalf as National Clinical Lead for Rare Cancers on NHS England’s National Cancer Board.
Read Christie doctor appointed NHS National Clinical Lead for Rare Cancers Article
Minister James Frith MP, Parliamentary Under-Secretary of State for Health Innovation at the Department of Health and Social Care, visited The Christie on 9 September 2026 to observe how cutting-edge medical technology and clinical research are transforming cancer care.
Read Health Innovation Minister visits The Christie to see pioneering AI and precision cancer care in action Article
Patients at The Christie have once again given positive feedback about their experience of inpatient care in the annual national adult inpatient survey in 2025.
Read Patients continue to rate inpatient care at The Christie highly Article
The largest radiotherapy clinical trial for breast cancer ever to run in the UK is recruiting patients at The Christie NHS Foundation Trust in Manchester. It aims to cut treatment time for patients receiving a radiotherapy “boost” for breast cancer.
Read UK’s largest breast cancer radiotherapy trial aims to cut radiotherapy time Article
Researchers at The Christie NHS Foundation Trust have published one of the largest studies to date exploring whether the time-of-day cancer patients receive immunotherapy could influence how well treatment works.
Read Christie study suggests timing of immunotherapy may influence cancer outcomes Article
TOPICAL, a clinical trial led by The Christie NHS Foundation Trust, is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.
Read Trial drug could reduce side-effects of blood cancer treatments Article
A woman who has spent more than five years living with advanced ovarian cancer has become the first patient in the world to receive a pioneering new cell therapy.
Read First patient receives pioneering new cell therapy at The Christie Article
The Christie at Salford, one of The Christie NHS Foundation Trust’s local treatment centres, is celebrates its 15th birthday this July. The number of patients treated at the centre has grown significantly since it opened, from 760 patients in the first 12 months to around 1,650 patients in 2025.
Read Celebrating 15 years of cancer care in Salford Article
Mark England was diagnosed with bladder cancer in early December last year. He is the first patient to join the MANIFEST study, one of the largest immunotherapy studies in the country.
Read Sandbach man is the first in the UK to join landmark immunotherapy study Article
The Christie NHS Foundation Trust and Mid Cheshire Hospitals NHS Foundation Trust have signed a Memorandum of Understanding (MoU), marking a significant step forward in a shared ambition to bring more specialist cancer care closer to home for local people.
Read The Christie and Mid Cheshire Hospitals join forces to bring specialist cancer care to Crewe Article
We are pleased to announce that The Christie will be one of the second wave of applicants to be assessed for advanced foundation trust status.
Read The Christie selected for second wave of Advanced Foundation Trust Programme Article
Terence Moore was recently diagnosed with AL amyloidosis, a rare cancerous condition and is currently having treatment at The Christie at Macclesfield.
Read Chester man thanks the NHS for saving his life multiple times Article
The Senior Adult Oncology Service at The Christie is helping patients like Vernon Bradshaw, 90, who was diagnosed with stage one lung cancer in January 2026 after visiting his GP with a persistent cough.
Read The Senior Adult Oncology team at The Christie made me feel worthwhile says 90-year-old cancer patient Article
Results from a global clinical trial show that using a brand-new drug – currently called GRWD5769 – with an existing type of immunotherapy called cemiplimab can shrink tumours or keep them stable in people with six different advanced and hard-to-treat cancers.
Read New drug shrinks tumours in six advanced and hard-to-treat cancers Article
The Princess of Wales visited The Christie today (Thursday 4 June 2026) to learn more about the healing power of holistic therapies, alongside clinical care, for people living with and beyond cancer.
Read The Princess of Wales visits The Christie Article
Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning.
Read Gene test can safely spare many breast cancer patients of chemotherapy Article
47-year-old Jodie Goulborn from Merseyside has a type of brain tumour called a glioma. A ground-breaking new drug called vorasidenib has been keeping it at bay for over 4 years, and now that drug is available on the NHS. It’s the first time a new adult brain tumour treatment has been approved in 20 years.
Read Christie patient thankful for ground-breaking new brain tumour drug Article
The Christie NHS Foundation Trust in Manchester has appointed Professor Martin Vernon, a nationally recognised expert in older people’s care, to help develop its Senior Adult Oncology Service.
Read National expert in geriatric care appointed to expand pioneering service at The Christie for older patients Article
For more than 3 decades, Jacqui Stringer has helped reshape how care is delivered to cancer patients at The Christie - now she prepares to retire after 34 years.
Read Pioneer of integrative therapies at The Christie reflects on a revolution in cancer care Article
Recent media reports about a data breach affecting the UK Biobank may have caused concern for patients - the UK Biobank is entirely separate to the Manchester Cancer Research Centre Biobank.
Read UK Biobank data breach media reports Article
48-year-old Nick Cleworth, a train driver and dad-of-one from Swinton, is free from rectal cancer after taking part in a clinical trial at The Christie NHS Foundation Trust.
Read Dad free from rectal cancer after taking part in clinical trial at The Christie Article
A dad who once ran the London Marathon and cycled 50 to 100 miles a week has described how cancer treatment left him unable to walk. Thanks to specialist care at The Christie in Manchester, he has rebuilt his life.
Read After running a marathon, I suddenly found myself unable to walk, but The Christie helped me get my life back Article
A Salford man who has had blood cancer twice is recovering well and enjoying life after receiving a life-saving stem cell transplant at The Christie NHS Foundation Trust, a specialist cancer centre in Manchester.
Read Brother flies from New York to donate stem cells after rare blood cancer returns Article
Patients with malignant and non-malignant haematological conditions from Cheshire have praised the changes in their care and treatment at Leighton Hospital since the service transferred to The Christie last April.
Read The Christie marks the first anniversary of its haematology service at Leighton Hospital Article
A Bowdon nurse, who has dedicated more than four decades to caring for people with cancer, has been highlighting the unique role that clinical nurse specialists play at The Christie, having first joined the organisation in 1983.
Read The pioneering Bowdon nurse who has been caring for cancer patients at The Christie for more than 40 years Article
Lorraine Burgess is stepping down from her role as lead dementia nurse consultant at The Christie after a remarkable 51-year career in healthcare, including the past 14 years helping transform support for cancer patients at The Christie who are living with dementia.
Read The Christie’s dementia nurse consultant Lorraine to retire after 51 years caring for NHS patients Article
The TORPEdO trial, co-led by The Christie, found that standard intensity-modulated radiotherapy (IMRT) is as effective as proton beam therapy for treating oropharyngeal cancer, a type of throat cancer.
Read Results of UK's first proton beam therapy study published in The Lancet Article
Researchers will investigate whether halving the dose of hormone therapies such as abiraterone and enzalutamide can offer patients the same life-extending benefits but with fewer side effects.
Read Hormone-blocking prostate cancer trial opens at The Christie Article
A retired nurse from Hollinwood, Oldham, is benefiting from a new way of getting lifesaving renal cancer treatment that takes minutes rather than hours only 20 minutes from her home.
Read Oldham patient benefits from faster cancer treatment from The Christie Article
Young cancer patients can now use Minecraft to explore what it’s like inside the proton beam therapy centre at The Christie, in Manchester.
Read Proton beam therapy comes to Minecraft to help children prepare for cancer treatment at The Christie Article
A message from Dr Neil Bayman, Executive Medical Director at The Christie, on the launch of the Government’s new cancer plan .
Read Launch of the National Cancer Plan Article
Duncan Edmonstone from Sandbach in Cheshire was diagnosed with stage 4 lung cancer 6 years ago. He started on a targeted treatment called alectinib, which he is still on today.
Read Lung cancer patient doing well after 6 years thanks to targeted treatment Article
Thank you to everyone who has contacted us about the Federated Data Platform (FDP). We recognise that how the NHS uses data is important to patients and the public, and we understand why people want clarity and reassurance about security, confidentiality, transparency, and ethics.
Read Statement on the Federated Data Platform (FDP) Article
Graham Caveney, a 61-year-old author and journalist from Accrington, has seen his advanced food pipe (oesophageal) cancer shrink by 50% thanks to a drug trial at The Christie.
Read Author sees advanced cancer shrink by half on clinical trial at The Christie Article
Sam Birchall, the lead guitarist in indie band The Lilacs, is the first person in Europe to have a lymph node removal operation for testicular cancer that has spread and go home the same day.
Read Indie guitarist is first in Europe to have groundbreaking robotic operation Article
Researchers at The Christie are looking at whether 2 de-escalated (lower doses) of targeted radiotherapy are as effective as 2 regular doses at treating men with intermediate-risk prostate cancer.
Read New lower-dose radiotherapy trial opens at The Christie Article
Read the press releases, updates and news stories from The Christie NHS Foundation Trust from 2025, including patient stories and staff stories.
Read News stories archive 2025 Article
Read the press releases, updates and news stories from The Christie NHS Foundation Trust from 2024, including patient stories and staff stories.
Read News stories archive 2024 Article
Read the press releases, updates and news stories from The Christie NHS Foundation Trust from 2023, including patient stories and staff stories.
Read News stories archive 2023 Article